Functional similarities among genes regulated by Oct4 in human mesenchymal and embryonic stem cells

Stem Cells

Volumn 25, Issue 12, 2007, Pages 3143-3154

  Greco, Steven J ^a   Liu, Katherine ^a   Rameshwar, Pranela ^b  

^a The State University of New Jersey   (United States)

^b RUTGERS NEW JERSEY MEDICAL SCHOOL   (United States)

Author keywords

Embryonic stem cell; Mesenchymal stem cell; OCT4; Plasticity chromatin immunoprecipitation DNA selection and ligation

Indexed keywords

OCTAMER TRANSCRIPTION FACTOR 4; TRANSCRIPTION FACTOR; TRANSCRIPTION FACTOR NANOG; TRANSCRIPTION FACTOR SOX2;

ADIPOCYTE; ARTICLE; BONE CELL; BONE MARROW; CARTILAGE; CELL CYCLE PROGRESSION; CELL DIFFERENTIATION; CELL LINEAGE; CHROMATIN IMMUNOPRECIPITATION; CONTROLLED STUDY; EMBRYO; EMBRYONIC STEM CELL; GENE CONTROL; GENE FUNCTION; HUMAN; HUMAN CELL; MESENCHYME CELL; MESODERM; NERVE CELL; NUCLEOTIDE SEQUENCE; PLURIPOTENT STEM CELL; PROTEIN EXPRESSION; PROTEIN FUNCTION; REGULATORY MECHANISM; STROMA CELL; TRANSCRIPTION REGULATION;

CELL DIFFERENTIATION; CELLS, CULTURED; EMBRYONIC STEM CELLS; GENE EXPRESSION REGULATION, DEVELOPMENTAL; HUMANS; MESENCHYMAL STEM CELLS; OCTAMER TRANSCRIPTION FACTOR-3;

EID: 37349051446     PISSN: 10665099     EISSN: None     Source Type: Journal    
DOI: 10.1634/stemcells.2007-0351     Document Type: Article

References (40)

1. Baharvand H, Jafary H, Massumi M et al. Generation of insulin-secreting cells from human embryonic stem cells. Dev Growth Differ 2006;48:323-332.
2. Wang Q, Matsumoto Y, Shindo T et al. Neural stem cells transplantation in cortex in a mouse model of Alzheimer's disease. J Med Invest 2006;53:61-69.
3. Snyder BJ, Olanow CW. Stem cell treatment for Parkinson's disease: An update for 2005. Curr Opin Neurol 2005;18:376-385.
4. Yan J, Xu L, Welsh AM et al. Combined immunosuppressive agents or CD4 antibodies prolong survival of human neural stem cell grafts and improve disease outcomes in ALS transgenic mice. STEM CELLS 2006;24:1976-1985.
5. Jiang W, Ma A, Wang T et al. Intravenous transplantation of mesenchymal stem cells improves cardiac performance after acute myocardial ischemia in female rats. Transpl Int 2006;19:570-580.
6. Lerou PH, Daley GQ. Therapeutic potential of embryonic stem cells. Blood Rev 2005;19:321-331.
7. Cheng N, Janumyan YM, Didion L et al. Bcl-2 inhibition of T-cell proliferation is related to prolonged T-cell survival. Oncogene 2004;23: 3770-3780.
8. Bianco P, Riminucci M, Gronthos S et al. Bone marrow stromal stem cells: Nature, biology, and potential applications. STEM CELLS 2001; 19:180-192.
9. Deans RJ, Moseley AB. Mesenchymal stem cells: Biology and potential clinical uses. Exp Hematol 2000;28:875-884.
10. Caplan AI. The mesengenic process. Clin Plast Surg 1994;21:429-435.
11. Jeon SJ, Oshima K, Heller S et al. Bone marrow mesenchymal stem cells are progenitors in vitro for inner ear hair cells. Mol Cell Neurosci 2007;34:59-68.
12. Eberhardt M, Salmon P, von Mach MA et al. Multipotential nestin and Isl-1 positive mesenchymal stem cells isolated from human pancreatic islets. Biochem Biophys Res Commun 2006;345:1167-1176.
13. Choi KS, Shin JS, Lee JJ et al. In vitro trans-differentiation of rat mesenchymal cells into insulin-producing cells by rat pancreatic extract. Biochem Biophys Res Commun 2005;330:1299-1305.
14. Ong SY, Dai H, Leong HW. Inducing hepatic differentiation of human mesenchymal stem cells in pellet culture. Biomaterials 2006;27:4087-4097.
15. Cho KJ, Trzaska KA, Greco SJ et al. Neurons derived from human mesenchymal stem cells show synaptic transmission and can be induced to produce the neurotransmitter substance P by interleukin-1 alpha. STEM CELLS 2005;23:383-391.
16. Greco SJ, Zhou C, Ye JH et al. An interdisciplinary approach and characterization of neuronal cells transdifferentiated from human mesenchymal stem cells. Stem Cells Dev 2007 (in press).
17. Tondreau T, Meuleman N, Delforge A et al. Mesenchymal stem cells derived from CD133-positive cells in mobilized peripheral blood and cord blood: Proliferation, Oct4 expression, and plasticity. STEM CELLS 2005;23:1105-1112.
18. Pan GJ, Chang ZY, Scholer HR et al. Stem cell pluripotency and transcription factor Oct4. Cell Res 2002;12:32132-32139.
19. Boiani M, Scholer HR. Regulatory networks in embryo-derived pluripotent stem cells. Nat Rev Mol Cell Biol 2005;6:872-884.
20. Potian JA, Aviv H, Ponzio NM et al. Veto-like activity of mesenchymal stem cells: Functional discrimination between cellular responses to alloantigens and recall antigens. J Immunol 2003;171:3426-3434.
21. Protocol outlined by WiCell Research Institute. Available at http://www.wicell.org. Accessed June 15, 2006.
22. NIH registry of available human ESC lines. Available at http://stemcells.nih.gov/research/registry. Accessed June 15, 2006.
23. Genomatix MatInspector Transcription Factor Binding Site Tool. Available at http://www.genomatix.de. Accessed November 10, 2006.
24. Kwon YS, Garcia-Bassets I, Hutt KR et al. Sensitive ChIP-DSL technology reveals an extensive estrogen receptor alpha-binding program on human gene promoters. Proc Natl Acad Sci U S A 2007;104:4852-4857.
25. Garcia-Bassets I, Kwon YS, Telese F et al. Histone methylation-dependent mechanisms impose ligand dependency for gene activation by nuclear receptors. Cell 2007;128:505-518.
26. Li Z, Van Calcar S, Qu C et al. A global transcriptional regulatory role for c-Myc in Burkitt's lymphoma cells. Proc Natl Acad Sci U S A 2003;100:8164-8169.
27. Ren B, Dynlacht BD. Use of chromatin immunoprecipitation assays in genome-wide location analysis of mammalian transcription factors. Methods Enzymol 2004;376:304-315.
28. Bandari PS, Qian J, Yehia G et al. Differences in the expression of neurokinin receptor in neural and bone marrow mesenchymal cells: Implications for neuronal expansion from bone marrow cells. Neuropeptides 2002;36:13-21.
29. Lansdorp PM. Role of telomerase in hematopoietic stem cells. Ann NY Acad Sci 2005;1044:220-227.
30. Gronthos S, Zannettino AC, Hay SJ et al. Molecular and cellular characterisation of highly purified stromal stem cells derived from human bone marrow. J Cell Sci 2003;116:1827-1835.
31. Hoogduijn MJ, Gorjup E, Genever PG. Comparative characterization of hair follicle dermal stem cells and bone marrow mesenchymal stem cells. Stem Cells Dev 2006;15:49-60.
32. Entrez gene algorithm. Available at http://www.ncbi.nlm.nih.gov/entrez. Accessed January 27, 2007.
33. Keyes WM, Wu Y, Vogel H et al. p63 deficiency activates a program of cellular senescence and leads to accelerated aging. Genes Dev 2005;19:1986-1999.
34. Vacanti V, Kong E, Suzuki G et al. Phenotypic changes of adult porcine mesenchymal stem cells induced by prolonged passaging in culture. J Cell Physiol 2005;205:194-201.
35. Episkopou V. SOX2 functions in adult neural stem cells. Trends Neurosci 2005;28:219-221.
36. Seruya M, Shah A, Pedrotty D et al. Clonal population of adult stem cells: Life span and differentiation potential. Cell Transplant 2004;13:93-101.
37. Mauney JR, Volloch V, Kaplan DL. Role of adult mesenchymal stem cells in bone tissue engineering applications: Current status and future prospects. Tissue Eng 2005;11:787-802.
38. Bentzon JF, Stenderup K, Hansen FD et al. Tissue distribution and engraftment of human mesenchymal stem cells immortalized by human telomerase reverse transcriptase gene. Biochem Biophys Res Commun 2005;330:633-640.
39. Loh YH, Wu Q, Chew JL et al. The Oct4 and Nanog transcription network regulates pluripotency in mouse embryonic stem cells. Nat Genet 2006;38:431-444.
40. Campbell PA, Perez-Iratxeta C, Andrade-Navarro MA et al. Oct4 targets regulatory nodes to modulate stem cell function. PLoS ONE 2007;2:e553.